News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
792,315 Results
Type
Article (78892)
Company Profile (292)
Press Release (713131)
Section
Business (216977)
Career Advice (3525)
Deals (38115)
Drug Delivery (126)
Drug Development (89477)
Employer Resources (186)
FDA (17810)
Job Trends (16544)
News (374767)
Policy (37451)
Tag
2024 BioCapital Digital (11)
2024 BioForest Digital (5)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (9)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (15)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (7)
2024 Genetown Digital (5)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (10)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2983)
Academic (2)
Accelerated approval (3)
Adcomms (29)
Allergies (88)
Alliances (54963)
ALS (93)
Alzheimer's disease (1476)
Antibody-drug conjugate (ADC) (140)
Approvals (17779)
Artificial intelligence (274)
Autoimmune disease (21)
Automation (14)
Bankruptcy (376)
Best Places to Work (12469)
BIOSECURE Act (20)
Biosimilars (115)
Biotechnology (198)
Bladder cancer (65)
Brain cancer (29)
Breast cancer (272)
Cancer (2160)
Cardiovascular disease (188)
Career advice (2989)
Career pathing (33)
CAR-T (159)
Cell therapy (452)
Cervical cancer (21)
Clinical research (71979)
Collaboration (838)
Compensation (434)
Complete response letters (30)
COVID-19 (2841)
CRISPR (42)
C-suite (232)
Cystic fibrosis (105)
Data (2016)
Decentralized trials (2)
Denatured (42)
Depression (51)
Diabetes (273)
Diagnostics (6813)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (128)
Drug pricing (120)
Drug shortages (32)
Duchenne muscular dystrophy (92)
Earnings (85066)
Editorial (39)
Employer branding (23)
Employer resources (160)
Events (120871)
Executive appointments (688)
FDA (18985)
Featured Employer (54)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (746)
Gene editing (109)
Generative AI (29)
Gene therapy (322)
GLP-1 (811)
Government (5056)
Grass and pollen (5)
Guidances (48)
Healthcare (20605)
Huntington's disease (24)
IgA nephropathy (26)
Immunology and inflammation (129)
Indications (27)
Infectious disease (2987)
Inflammatory bowel disease (146)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (91)
Interviews (670)
IPO (17323)
IRA (48)
Job creations (4540)
Job search strategy (2479)
Kidney cancer (10)
Labor market (32)
Layoffs (530)
Leadership (20)
Legal (9087)
Liver cancer (76)
Lung cancer (315)
Lymphoma (139)
Machine learning (4)
Management (65)
Manufacturing (298)
MASH (67)
Medical device (14269)
Medtech (14274)
Mergers & acquisitions (21286)
Metabolic disorders (718)
Multiple sclerosis (77)
NASH (23)
Neurodegenerative disease (102)
Neuropsychiatric disorders (30)
Neuroscience (2015)
NextGen: Class of 2025 (7375)
Non-profit (5053)
Northern California (2450)
Now hiring (28)
Obesity (386)
Opinion (270)
Ovarian cancer (75)
Pain (89)
Pancreatic cancer (79)
Parkinson's disease (145)
Partnered (22)
Patents (218)
Patient recruitment (97)
Peanut (51)
People (63364)
Pharmaceutical (66)
Pharmacy benefit managers (21)
Phase I (22209)
Phase II (31328)
Phase III (23587)
Pipeline (1089)
Podcasts (111)
Policy (133)
Postmarket research (3397)
Preclinical (9917)
Press Release (71)
Prostate cancer (99)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (403)
Real estate (6913)
Recruiting (73)
Regulatory (25453)
Reports (45)
Research institute (2641)
Resumes & cover letters (550)
Rett syndrome (3)
RNA editing (4)
RSV (45)
Schizophrenia (76)
Series A (132)
Series B (84)
Service/supplier (17)
Sickle cell disease (57)
Southern California (2158)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (33)
Startups (3933)
State (2)
Stomach cancer (16)
Supply chain (63)
The Weekly (67)
United States (22099)
Vaccines (766)
Venture capitalists (38)
Webinars (13)
Weight loss (280)
Women's health (38)
Worklife (18)
Date
Today (164)
Last 7 days (789)
Last 30 days (2985)
Last 365 days (35543)
2025 (8730)
2024 (37141)
2023 (42001)
2022 (53298)
2021 (58163)
2020 (57157)
2019 (50809)
2018 (38701)
2017 (36054)
2016 (36420)
2015 (42560)
2014 (36805)
2013 (33295)
2012 (34904)
2011 (34939)
2010 (34738)
Location
Africa (1150)
Alabama (55)
Alaska (7)
Arizona (231)
Arkansas (14)
Asia (47110)
Australia (8276)
California (5660)
Canada (1900)
China (508)
Colorado (257)
Connecticut (276)
Delaware (133)
Europe (108667)
Florida (836)
Georgia (205)
Idaho (62)
Illinois (574)
India (26)
Indiana (302)
Iowa (8)
Japan (146)
Kansas (104)
Kentucky (25)
Louisiana (9)
Maine (68)
Maryland (871)
Massachusetts (4349)
Michigan (223)
Minnesota (389)
Mississippi (2)
Missouri (86)
Montana (31)
Nebraska (25)
Nevada (58)
New Hampshire (69)
New Jersey (1653)
New Mexico (31)
New York (1650)
North Carolina (1031)
North Dakota (8)
Northern California (2450)
Ohio (203)
Oklahoma (15)
Oregon (37)
Pennsylvania (1254)
Puerto Rico (10)
Rhode Island (26)
South America (1507)
South Carolina (19)
South Dakota (1)
Southern California (2158)
Tennessee (95)
Texas (857)
Utah (174)
Virginia (144)
Washington D.C. (65)
Washington State (533)
West Virginia (3)
Wisconsin (57)
792,315 Results for "european organization for research and treatment of cancer".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast
- Company listed in Research and Markets’ announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - “U.S. breast cancer screening and diagnostic [device] market was valued at $1.55 billion in 2024 and is anticipated to reach $2.34 billion by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-20301"- -Report supports Company’s regulatory strategy for IzoView Breast CT, reinforces high demand for new breast imaging modalities, strengthens the potential for rapid market adoption and significant market share -
January 17, 2025
·
8 min read
News
HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference
October 7, 2024
·
15 min read
Press Releases
SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2025
March 18, 2025
·
1 min read
Press Releases
NUS researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment
January 24, 2025
·
4 min read
Press Releases
Cancer Research UK, Cytovation and the Norwegian Cancer Society collaborate to advance treatment for rare cancer
January 23, 2025
·
5 min read
Press Releases
TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical Cancer
March 31, 2025
·
17 min read
Press Releases
MAIA Biotechnology Announces Poster Presentation at ESMO’s European Lung Cancer Congress 2025
March 25, 2025
·
5 min read
Press Releases
European Commission approves LAZCLUZE®▼ (lazertinib) in combination with RYBREVANT®▼ (amivantamab) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer
January 21, 2025
·
16 min read
Biotech Beach
City of Hope Researchers to Present Investigational Treatments for Colorectal, Kidney and Blood Cancers at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
World-renowned physicians and researchers from City of Hope®, one of the largest cancer research and treatment organizations in the United States, will present new data and offer expert perspectives on leading-edge cancer research and treatments in development at the 2024 ASCO Annual Meeting.
May 23, 2024
·
11 min read
Propanc Biopharma Receives Certificate of Grant for “Composition of Proenzymes for Cancer Treatment” Patent from European Patent Office
Propanc Biopharma, Inc. today announced that a certificate of grant for the Company’s “composition of proenzymes for cancer treatment,” patent was received from the European Patent Office.
April 16, 2024
·
3 min read
1 of 79,232
Next
